Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

5:30 PM - 5:35 PM ET

1132 - Functional Radiosensitivity Assay Identifies Immune Markers Associated with Late Rectal Bleeding after Prostate Radiotherapy: The TransPROUST Study
Speaker: Debbi, Kamel, MD, PhD - CHU Henri Mondor, Creteil
5:30 PM - 5:40 PM ET

229 - Sexual Health and Post-Treatment Symptoms among Female Survivors of Anal Cancer
Speaker: Raldow, Ann, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA
5:30 PM - 5:40 PM ET

234 - Development and Comparative Evaluation of Low-Cost Gelatin-Agar and Silicone-Based Phantoms to Expand Access to Ultrasound-Guided Brachytherapy Training In Resource-Limited Settings
Speaker: Hernandez Martinez, Daniel, MD - Universidad Autonoma de Nuevo Leon, San Nicolas de los Garza, Nuevo Leon
5:35 PM - 5:55 PM ET

Questions & Answers
Speaker: Zhang, Chi, MD, PhD - Mayo Clinic Arizona, Phoenix, AZ
5:35 PM - 5:55 PM ET

Questions & Answers
Speaker: Sayan, Mutlay, MD - Brigham and Women's Hospital/Dana-Farber, Boston, MA
5:35 PM - 5:55 PM ET

Questions & Answers
Speaker: Remick, Jill, MD - Emory University , Atlanta, GA
5:35 PM - 5:55 PM ET

Questions and Answers
Speaker: Ohri, Nitin, MD, MS - Albert Einstein College of Medicine, Bronx, NY
5:35 PM - 5:55 PM ET

Questions and Answers
Speaker: Hao, Yao, PhD - Washington Univ School of Medicine, St. Louis, MO
5:40 PM - 5:50 PM ET

235 - Early Institutional Experience with Online Adaptive Radiotherapy in Latin America: Workflow Time Analysis
Speaker: De La Mata Moya, M. Dolores, MD, PhD, MPH - Centro Medico ABC, Mexico City, CIUDAD DE MEXICO
5:40 PM - 5:50 PM ET

Discussant
Speaker: Tchelebi, Leila, MD - Northwell Health, Lake Success, NY
5:50 PM - 6:00 PM ET

230 - Pathological Complete Response and ctDNA Analyses Results from a Randomized Phase III Trial of Neoadjuvant Chemotherapy or Chemoradiotherapy plus Sintilimab vs. Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Speaker: Lv, Jiahua, MD, PhD - Sichuan Cancer Hospital and Institute, chengdu, Sichuan
5:50 PM - 6:00 PM ET

236 - AI in LMIC Radiotherapy: Clinical Performance and Implementation Feasibility
Speaker: Ndassi, Doris - Johns Hopkins, Washington, DC